$STXS News
Last published 1d ago
- 1d agoSTXSStereotaxis, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 1.01 Item 2.02 Item 2.03 Item 3.02 Item 9.01
- 1d agoSTXSStereotaxis Reports 2026 Third Quarter Financial Results & Business UpdatesGlobeNewswireST. LOUIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the third quarter ended September 30, 2026.
- 1d agoSTXSStereotaxis Announces Convertible Note Financing of Up To $24 MillionGlobeNewswireST. LOUIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has entered into definitive agreements with investors for a convertible note financing of up to $24 million.
- 1w agoSTXSFirst-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCTGlobeNewswire100% clinical success and no device-related adverse events in 20 First-in-Human Percutaneous Coronary Intervention procedures with next-generation robotic systemRobocath system demonstrates ability to efficiently and
- 1w agoSTXSCanon Medical and Stereotaxis Collaborate to Advance Robotic ElectrophysiologyGlobeNewswireCollaboration brings together Canon’s Alphenix interventional fluoroscopy system and Stereotaxis’ GenesisX robotic technologyTechnologies will be presented at TCT 2026 in the Canon booth TUSTIN, Calif. and ST. LOUIS,
- 2w agoSTXSStereotaxis Announces First Robotic Magnetic Navigation System in LatviaGlobeNewswirePauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the treatment of cardiac arrhythmia in LatviaFirst procedures successfully
- 3w agoSTXSStereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026GlobeNewswireST. LOUIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release
- 1mo agoSTXSStereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026GlobeNewswireNew digital technologies, including Synchrony and SynX, will be featured at HRXStereotaxis CEO to join main-stage panel on Autonomous EP Systems ST. LOUIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS),
- 2mo agoSTXSUniversity of Szeged Celebrates Strongest First Month of Robotic Cardiology ProgramGlobeNewswireUniversity of Szeged installed Hungary’s first Robotic Magnetic Navigation system in JulyOver 70 patients with all forms of arrhythmia treated robotically to date, a record pace of use globallyRobotics enabled
- 3mo agoSTXSStereotaxis Reports 2026 Second Quarter Financial Results & Business UpdatesGlobeNewswireRobotic catheter revenue surpasses $1M in the quarter, growing 270% sequentiallyFirst GenesisX robotic system purchase by US hospital to be installed this fallMultiple Synchrony digital operating room systems sold and
- 3mo agoMOBIINSPSTXSMobia Medical Appoints Myriam Curet, M.D., to its Board of DirectorsGlobeNewswireAUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (NASDAQ:MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments,
- 3mo agoSTXSStereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026GlobeNewswireST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release
- 3mo agoSTXSUniversity of Szeged Pioneers First Robotic Cardiology Program in HungaryGlobeNewswireFirst Robotic Magnetic Navigation system installed in HungaryUniversity of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using
- 4mo agoSTXSStereotaxis Completes Acquisition of RobocathGlobeNewswireST. LOUIS and ROUEN, France, July 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has
- 6mo agoSTXSStereotaxis Reports 2026 First Quarter Financial Results & Business UpdatesGlobeNewswireProprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as EuropeSynchrony digital operating room system
- 6mo agoSTXSStereotaxis Announces First MAGiC Procedures in the United StatesGlobeNewswireST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US
- 6mo agoSTXSStereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026GlobeNewswireST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial
- 7mo agoSTXSStereotaxis Announces Definitive Agreement to Acquire RobocathGlobeNewswireST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has
- 7mo agoSTXSStereotaxis Announces FDA Clearance and Launch of Synchrony SystemGlobeNewswireST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food
- 8mo agoSTXSStereotaxis Reports 2025 Full Year Financial ResultsGlobeNewswireST. LOUIS, March 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth
- 9mo agoSTXSStereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026GlobeNewswireST. LOUIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial
- 9mo agoSTXSKlinikum Fürth Establishes Leading Robotic Heart Arrhythmia ProgramGlobeNewswireST. LOUIS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of a new robotic
- 11mo agoSTXSStereotaxis to Participate in Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswireST. LOUIS, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that the company will participate
- 1y agoSTXSStereotaxis Reports 2025 Third Quarter Financial ResultsGlobeNewswireST. LOUIS, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third
- 1y agoSTXSGenesisX Robotic Magnetic Navigation System Receives U.S. FDA ClearanceGlobeNewswireST. LOUIS, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received U.S. Food and
- 1y agoSTXSStereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025GlobeNewswireST. LOUIS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial
- 1y agoSTXSStereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath LabsGlobeNewswireST. LOUIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE Mark in Europe and
- 1y agoSTXSStereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac ArrhythmiasGlobeNewswireST. LOUIS and MARLBOROUGH, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and CardioFocus, Inc., a
- 1y agoSTXSErasmus Medical Center Advances Cardiovascular Care with Genesis Robotic SystemGlobeNewswireST. LOUIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced successful first procedures by
- 1y agoSTXSFirst US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep CatheterGlobeNewswireST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the successful completion of the
- 1y agoSTXSStereotaxis to Present at Upcoming Investor ConferencesGlobeNewswireST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and
- 1y agoSTXSStereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025GlobeNewswireST. LOUIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its technology will be featured
- 1y agoSTXSStereotaxis, Inc. (STXS) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoSTXSStereotaxis Reports 2025 Second Quarter Financial ResultsGlobeNewswireST. LOUIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the second
- 1y agoSTXSStereotaxis Receives U.S. FDA Clearance for MAGiC Sweep CatheterGlobeNewswireST. LOUIS, July 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food
- 1y agoSTXSStereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025GlobeNewswireST. LOUIS, July 23, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial
- 1y agoSTXSStereotaxis Announces $12.5 Million Registered Direct Offering of Common StockGlobeNewswireLed by Strategic Industry Partner and Select Institutional InvestorsProceeds Strengthen Balance Sheet and Support Commercialization of Innovation Strategy ST. LOUIS, July 17, 2025 (GLOBE NEWSWIRE) -- Stereotaxis,
- 1y agoSTXSFirst Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac ElectrophysiologyGlobeNewswireST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the publication of initial
- 1y agoSTXSStereotaxis Reports 2025 First Quarter Financial ResultsGlobeNewswireST. LOUIS, May 12, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first
- 1y agoSTXSStereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025GlobeNewswireST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial
- 1y agoSTXSStereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025GlobeNewswireST. LOUIS, April 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced today it will host a live
- 1y agoSTXSStereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect ProgramGlobeNewswireST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA highlighted
- 1y agoSTXSStereotaxis to Present at 37th Annual Roth ConferenceGlobeNewswireST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and
- 1y agoSTXSStereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular SurgeryGlobeNewswireST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory submission for
- 1y agoSTXSStereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory ClearanceGlobeNewswireST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory submission for
- 1y agoSTXSStereotaxis Reports 2024 Full Year Financial ResultsGlobeNewswireST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth
- 1y agoSTXSStereotaxis to Present at 45th Annual TD Cowen Healthcare ConferenceGlobeNewswireST. LOUIS, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and
- 1y agoSTXSStereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025GlobeNewswireST. LOUIS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial
- 1y agoSTXSStereotaxis Announces First GenesisX Robotic System OrderGlobeNewswireST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has received the first order
- 1y agoSTXSStereotaxis Receives CE Mark Approval for the MAGiC Ablation CatheterGlobeNewswireST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received European CE Mark